PeriferikArterHastalıklarınınGirişimsel Tedavisi: TekMerkez Sonuçları

GİRİŞ ve AMAÇ: Periferik arter hastalığında girişimsel tedavi yöntemlerinin popülerliği giderek artmaktadır. Bir çok vasküler alanda perkütan girişimler tedavide ilk sıradadır. Çalışmadaki amaç periferik arter hastalığında girişimsel tedavi yöntemlerinin merkezimizdeki sonuçlarını değerlendirmektir. YÖNTEM ve GEREÇLER: Temmuz 2011-Ekim 2015 arasındaki tanısal ve girişimsel işlemler retrospektif olarak tarandı. Girişimsel işlem verileri ve hastane içi istenmeyen olaylar hastane kayıtlarından incelendi. BULGULAR: Toplam 11224 adet anjiyografik işlem tarandı. Bunlardan 1144 tanesi periferik arter hastalığına yönelik tanısal işlemlerdi. Toplam 167 adet girişimsel işlem (ortalama yaş 62±10, %82'si erkek) tespit edildi. En sık alt ekstremite (n=101), ardından kranial (n=43), üst ekstremite (n=19) ve viseral (n=4) arterlere yönelik işlemler izlendi. Genel işlem başarısı %95'ti. Intravasküler stentler %81 (n=135) hastada kullanıldı. Hastane içi major istenmeyen olaylardan ölüm 1 (%0.6), serebrovasküler olay 2 %1.2), transfüzyon gerektiren kanama 1 (%0.6), diyaliz ihtiyacı 1 (%0.6) hastada izlendi. İşlem sonrası amputasyon veya miyokard enfarktüsü izlenmedi. Hastaların %89'u ertesi gün taburcu edildi. Karotis arter hastalığının girişimsel tedavisinde serebrovasküler olay oranı %4.7 (n=2) idi. İliak, femoral/popliteal ve subklavian/brakial arter girişimlerinde işlem başarısı sırasıyla %97, 92 ve 90 iken karotis/vertebral ve renal arter girişimlerinde başarı oranı %100'dü. TARTIŞMA ve SONUÇ: Periferik arter hasatlığının girişimsel tedavisi merkezimizde yüksek işlem başarısı ve kabul edilebilir istenmeyen olay insidansı ile yapılabilmektedir

PercutaneousTreatmentOfPeripheralArteryDisease: ASingleCenterExperience

INTRODUCTION: Interventional procedures for peripheral arterial disease have increasing popularity. Percutaneous interventions have become the first line therapy in many vascular territories. Aim of the present study is to evaluate the procedural results of percutaneous interventions for peripheral arterial disease in our single center. METHODS: Angiographic procedures performed between July 2011 and October 2015 were retrospectively evaluated. Interventional procedural data and in-hospital adverse events were acquired from hospital records. RESULTS: A total of 11224 angiographic procedures were screened. Of these, 1144 procedures were performed for the diagnosis of peripheral arterial disease. A total of 167 interventional procedures (mean age 62±10, 82% male) were detected. The most common procedure was lower extremity intervention (n=101), which was followed by cranial (n=43), upper extremity (n=19) and visceral (n=4) interventions. Overall procedural success rate was 95%. Intravascular stents were used in 82% (n=135) of patients. Among in-hospital adverse events, death was observed in 1 (0.6%), cerebrovascular events in 2 (1.2%), bleeding requiring transfusion in 1 (0.6%), dialysis requirement in 1 (0.6%) patient(s). Post-procedural amputation or myocardial infarction was not observed. Majority of patients (89%) were discharged from hospital the next day. Cerebrovascular event rate in carotid artery intervention was 4.7% (n=2). Iliac, femoral/popliteal and subclavian/brachial artery interventions had a procedural success rate of 97, 92 and 90%, respectively. Procedural success was 100% in carotid/vertebral and renal artery interventions DISCUSSION AND CONCLUSION: Percutaneous interventions for the management of peripheral arterial disease can be performed with high procedural success and acceptable adverse event rates in our center.

PDF

___

1.Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. J Am Coll Cardiol 2006;47:1239-312.
2.European Stroke Organisation, Tendera M, Aboyans V, Bartelink ML, et al. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J 2011;32:2851-906.
3.Norgren L, Hiatt WR, Dormandy JA, et al. InterSociety Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007;45:S5–S67.
4.Rooke TW, Hirsch AT, Misra S, et al. Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA Guideline Recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013;61:1555-70.
5.Davaine JM, Quérat J, Guyomarch B, et al. Primary stenting of TASC C and D femoropopliteal lesions: results of the STELLA register at 30 months. Ann Vasc Surg 2014;28:1686-96.
6.Biondi-Zoccai G. Why interventional cardiologists may be the most suitable specialists for the endovascular management of peripheral artery disease. Minerva Cardioangiol 2013;61:367-70.
7.Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. Eur Heart J 2012;33:2551-67.
8.Kandarpa K, Becker BJ, Hunink M, et al. Transcatheter interventions for the treatment of peripheral atherosclerotic lesions: part I. J Vasc Interv Radiol 2001;12:683–95.
9.Söder HK, Manninen HI, Jaakkola P, et al. Prospective trial of infrapopliteal artery balloon angioplasty for critical limb ischemia: angiographic and clinical results. J Vasc Interv Radiol 2000;11:1021-31.
10.Kudo T, Chandra FA, Ahn SS. Long-term outcomes and predictors of iliac angioplasty with selective stenting. J Vasc Surg 2005;42:466-75.
11.Gray WA, Yadav JS, Verta P, et al. The CAPTURE registry: results of carotid stenting with embolic protection in the post approval setting. Catheter Cardiovasc Interv 2007;69:341 – 348.
12.Katzen BT, Criado FJ, Ramee SR, et al. Carotid artery stenting with emboli protection surveillance study: thirty-day results of the CASES-PMS study. Catheter Cardiovasc Interv 2007; 70:316 – 323.
13.Wheatley K, Ives N, Gray R, et al. Revascularization versus medical therapy for renalartery stenosis. N Engl J Med 2009;361: 1953 – 1962.
14.Bax L, Woittiez AJ, Kouwenberg HJ, et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Ann Intern Med 2009;150:840 – 848.
15.Conrad MF, Kang J, Cambria RP, et al. Infrapopliteal balloon angioplasty for the treatment of chronic occlusive disease. J Vasc Surg 2009;50:799–805.
16.Wickenbrock I, Perings C, Maagh P, et al. Contrast medium induced nephropathy in patients undergoing percutaneous coronary intervention for acute coronary syndrome: differences in STEMI and NSTEMI. Clin Res Cardiol 2009;98:765-72.
17.Turan B, Erkol A, Gül M, et al. Effect of ContrastInduced Nephropathy on the Long-Term Outcome of Patients with Non-ST Segment Elevation Myocardial Infarction. Cardiorenal Med 2015;5:116-24.